Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines

Ana Carolina Martinez-Torres, Luis Gomez-Morales, Alan B. Martinez-Loria, Ashanti Concepcion Uscanga-Palomeque, Jose Manuel Vazquez-Guillen, Cristina Rodriguez-Padilla

Research output: Contribution to journalArticle

Abstract

Background. IMMUNEPOTENT-CRP® (I-CRP) is a bovine dialyzable leukocyte extract containing transfer factor. It is a cost-effective, unspecific active immunotherapy that has been used in patients with non-small cell lung cancer (NSCLC) as an adjuvant to reduce the side-effects of chemotherapy and radiotherapy, and has shown cytotoxic activity in vitro on different cancer cell lines. However, its mechanism of action against lung cancer cells has not been assessed. Therefore, the objective of this work was to assess the cytotoxic mechanism of I-CRP on lung cancer cell lines. Methods. We assessed cell viability through MTT assay on the NSCLC cell lines A549, A427, Calu-1, and INER-51 after treatment with I-CRP. To further understand the mechanisms of cell viability diminution we used fluorescence-activated cell sorting to evaluate cell death (annexin-V and propidium iodide [PI] staining), cell cycle and DNA degradation (PI staining), mitochondrial alterations (TMRE staining), and reactive oxygen species (ROS) production (DCFDA staining). Additionally, we evaluated caspase and ROS dependence of cell death by pretreating the cells with the pan-caspase inhibitor Q-VD-OPH and the antioxidant N-acetylcysteine (NAC), respectively. Results. Our data shows that I-CRP is cytotoxic to NSCLC cell lines in a dose and time dependent manner, without substantial differences between the four cell lines tested (A549, A427, Calu-1, and INER-51). Cytotoxicity is induced through regulated cell death and cell cycle arrest induction. I-CRP-induced cell death in NSCLC cell lines is characterized by DNA degradation, mitochondrial damage, and ROS production. Moreover, cell death is independent of caspases but relies on ROS production, as it is abrogated with NAC. Conclusion. Altogether, these results improve the knowledge about the cytotoxic activity of I-CRP on NSCLC cells, indicating that cell death, cell cycle arrest, DNA degradation and mitochondrial damage are important features, while ROS play the main role for I-CRP mediated cytotoxicity in lung cancer cells.

Original languageEnglish (US)
Article numbere7759
JournalPeerJ
Volume2019
Issue number9
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Keywords

  • Apoptosis
  • Cell cycle
  • Cell death
  • Mitochondrial damage
  • Non small cell lung cancer
  • NSCLC
  • Reactive oxygen species
  • ROS
  • Transfer factor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Fingerprint Dive into the research topics of 'Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines'. Together they form a unique fingerprint.

  • Cite this

    Martinez-Torres, A. C., Gomez-Morales, L., Martinez-Loria, A. B., Uscanga-Palomeque, A. C., Vazquez-Guillen, J. M., & Rodriguez-Padilla, C. (2019). Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines. PeerJ, 2019(9), [e7759]. https://doi.org/10.7717/peerj.7759